Featured News

Thank you for continuing to help us fight to protect coverage for the millions of Americans with celiac disease.

If you're interested in advancing treatments for cross-contact, and you meet the qualifications below, you may be able to participate in a study located in Seattle, Washington and Dallas, Texas.

ImmusanT, Inc., has announced that its therapeutic vaccine candidate, Nexvax2, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

An estimated 3 million Americans have celiac disease, yet 2 million are undiagnosed. What will YOU do to help? Join us in the fight for a cure by making a…

Laura Boone, 29, development manager for the Celiac Disease Foundation, was a senior in college when she was first diagnosed with celiac disease. No one could determine why she was feeling so sick.

Celiac Disease Foundation quoted in Healthline article covering the Nexvax2 therapeutic vaccine candidate.

On November 3, 2018, the Celiac Disease Foundation’s Team Gluten-Free Turkey Trot 5k Fun Run/Walk in New York and Los Angeles drew over 350 people of all ages and raised over $90,000. We are thrilled to share photos from the events with you. Continue reading to learn more about getting involved in raising awareness and funds for celiac disease in your community!

How the Gluten-Free Craze Affects Celiac Patients

The new, completely redesigned website offers visitors useful interactive features and easy access to essential information. Nov. 8, 2018 /Celiac.org/ — The Celiac Disease Foundation announced today the launch of its newly…

Celiac Disease Foundation Attends PCORI 2018 Annual Meeting and Advocacy Day